Concurrent massive breast enlargement, myasthenia gravis and dermopathy as manifestations of penicillamine toxicity in a Wilson's disease patient.
Penicillamine toxicity in Wilson's disease has been well reported but rarely seen now as newer agents are being used. We present a case who developed multiple rare complications of Penicillamine concurrently. Our patient is one of three siblings on Penicillamine, she was the only one who developed massive breast enlargement four months after commencing Penicillamine therapy, as well as dermatological adverse reactions and myasthenia gravis three more months later. All the adverse effects improved soon after substitution of the offending agent with Trientine.
Department of Hepatology, Selayang Hospital, Lebuhraya Selayang-Kepong, 68100 Batu Caves, Selangor, Malaysia. tansoeksiam@yahoo.com
S S
SS
Tan
S Abdul
SA
Latif
W Y
WY
Poh
D000293:Adolescent; D001940:Breast / Q000187:drug effects / Q000473:pathology*; D002614:Chelating Agents / Q000009:adverse effects*; D003875:Drug Eruptions / Q000209:etiology*; D005260:Female; D006527:Hepatolenticular Degeneration / Q000188:drug therapy; D006801:Humans; D009157:Myasthenia Gravis / Q000139:chemically induced*; D009929:Organ Size; D010396:Penicillamine / Q000009:adverse effects*
D002614:Chelating Agents; D010396:Penicillamine